Oxford Biomedica plc (LON:OXB)

Revenue by Segment

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Manufacturing Services	81.06M	68.35M	51.05M	-	-
Manufacturing Services Growth	18.60%	33.89%	-	-	-
Licences, Milestones and Royalties	5.27M	7.33M	6.68M	-	-
Licences, Milestones and Royalties Growth	-28.03%	9.59%	-	-	-
Development Services	60.11M	47.27M	31.81M	-	-
Development Services Growth	27.16%	48.64%	-	-	-
Procurement Services	22.30M	5.85M	-	-	-
Procurement Services Growth	281.24%	-	-	-	-
Product	-	-	-	86.00K	104.00K
Product Growth	-	-	-	-17.31%	-82.98%
Platform	-	-	-	139.90M	142.69M
Platform Growth	-	-	-	-1.96%	63.79%
Total	168.74M	128.80M	89.54M	139.99M	142.80M
Total Growth	31.01%	43.84%	-36.04%	-1.97%	62.77%

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United Kingdom	3.10M	6.92M	3.98M	49.94M	97.06M
United Kingdom Growth	-55.21%	73.80%	-92.02%	-48.55%	-
United States	141.59M	79.99M	65.76M	61.59M	20.82M
United States Growth	77.02%	21.64%	6.76%	195.88%	-
Europe	23.88M	41.89M	19.80M	28.06M	21.63M
Europe Growth	-42.98%	111.57%	-29.45%	29.73%	-59.04%
Rest of World	164.00K	-	-	396.00K	3.29M
Rest of World Growth	-	-	-	-87.95%	-90.59%
Total	168.74M	128.80M	89.54M	139.99M	142.80M
Total Growth	31.01%	43.84%	-36.04%	-1.97%	62.77%

Source: S&P Global Market Intelligence.